MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS, INC. ATELLICA IM BR 27.29 (BR)

Model Number 10995478

Device Problem High Readings (2459)

Patient Problem No Clinical Signs, Symptoms or Conditions (4582)

Event Date 01/28/2022

Event Type  malfunction  

Event Description

Customer observed elevated atellica im br 27.29 (br) results from a sample that was considered discordant with the replicate testing.The elevated results were not reported to the physician.There are no known reports of patient intervention or adverse health consequences due to the elevated discordant br 27.29 results.

Manufacturer Narrative

A us customer observed elevated atellica im br 27.29 (br) results from a sample that was considered discordant with the replicate testing.Siemens is investigating.The limitations section of the instructions for use states the following: "note do not interpret levels of ca 27.29 as absolute evidence of the presence or the absence of malignant disease.Before treatment, patients with confirmed breast carcinoma frequently have levels of ca 27.29 within the range observed in healthy individuals.Additionally, elevated levels of ca 27.29 can be observed in patients with nonmalignant diseases.Measurements of ca 27.29 should always be used in conjunction with other diagnostic procedures, including information from the patient's clinical evaluation.".

Manufacturer Narrative

The initial mdr 1219913-2022-00069 was filed on february 25, 2022.Additional information - march 08, 2022.A us customer observed a sample that initially recovered 45 u/ml with atellica im br 27.29 (br) assay kit lot 261.When the sample was repeated the next day on the same analyzer it recovered 144 u/ml.Further repeat testing of the same sample for 4 more times on the same analyzer 2 hours later it recovered 55.4, 40.5, 39.1, and 46.9 u/ml.The 144 u/ml result was an outlier but the other values were within the expected performance for the assay.In the initial mdr, the result of 55.4 u/ml was identified conservatively as a discordant result.A review of data indicated the issue was not due to the reagents or the calibration.A review of the reagent probe trace files did not show any issue with reagent addition.A review of the sample traces files suggested that there was particulate matter in the sample which could have interfered with the atellica im br 27.29 (br) assay and led to the elevated result of 144 u/ml.The cause of the 144 u/ml result when using atellica im br 27.29 (br) assay kit lot 261 could not be determined but siemens cannot rule out preanalytical factors or a sample issue.Based on the investigation, no product problem was identified.The customer is operational.No further action is required.In section h6, investigation findings and investigation conclusion codes were updated based on the investigation results.

• Brand Name: ATELLICA IM BR 27.29 (BR)
• Type of Device: BR 27.29 (BR)
• Manufacturer (Section D): SIEMENS HEALTHCARE DIAGNOSTICS, INC.; 511 benedict avenue; tarrytown NY 10591 5097
• Manufacturer (Section G): SIEMENS HEALTHCARE DIAGNOSTICS, INC; 333 coney street; east walpole MA 02032
• Manufacturer Contact: eiman sulieman ; 333 coney street; walpole, MA 02032 ; 7372808688
• MDR Report Key: 13600478
• MDR Text Key: 296474682
• Report Number: 1219913-2022-00069
• Device Sequence Number: 1
• Product Code: MOI
• UDI-Device Identifier: 00630414598055
• UDI-Public: 00630414598055
• Combination Product (y/n): N
• Reporter Country Code: US
• PMA/PMN Number: K982680
• Number of Events Reported: 1
• Summary Report (Y/N): N
• Report Source: Manufacturer
• Source Type: Health Professional,User Facility
• Reporter Occupation: Other Health Care Professional
• Type of Report: Initial,Followup
• Report Date: 04/01/2022

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Is this an Adverse Event Report?: No
• Is this a Product Problem Report?: Yes
• Device Operator: Health Professional
• Device Expiration Date: 09/19/2022
• Device Model Number: 10995478
• Device Catalogue Number: 10995478
• Device Lot Number: 261
• Was Device Available for Evaluation?: No
• Is the Reporter a Health Professional?: Yes
• Initial Date Manufacturer Received: 02/02/2022
• Initial Date FDA Received: 02/25/2022
• Supplement Dates Manufacturer Received: 03/08/2022
• Supplement Dates FDA Received: 04/01/2022
• Was Device Evaluated by Manufacturer?: Device Not Returned to Manufacturer
• Date Device Manufactured: 10/29/2021
• Is the Device Single Use?: No
• Is This a Reprocessed and Reused Single-Use Device?: No
• Type of Device Usage: Initial
• Patient Sequence Number: 1